- Revenue Cycle Management
- COVID-19
- Reimbursement
- Diabetes Awareness Month
- Risk Management
- Patient Retention
- Staffing
- Medical Economics® 100th Anniversary
- Coding and documentation
- Business of Endocrinology
- Telehealth
- Physicians Financial News
- Cybersecurity
- Cardiovascular Clinical Consult
- Locum Tenens, brought to you by LocumLife®
- Weight Management
- Business of Women's Health
- Practice Efficiency
- Finance and Wealth
- EHRs
- Remote Patient Monitoring
- Sponsored Webinars
- Medical Technology
- Billing and collections
- Acute Pain Management
- Exclusive Content
- Value-based Care
- Business of Pediatrics
- Concierge Medicine 2.0 by Castle Connolly Private Health Partners
- Practice Growth
- Concierge Medicine
- Business of Cardiology
- Implementing the Topcon Ocular Telehealth Platform
- Malpractice
- Influenza
- Sexual Health
- Chronic Conditions
- Technology
- Legal and Policy
- Money
- Opinion
- Vaccines
- Practice Management
- Patient Relations
- Careers
Morning Medical Update: Texas governor signs patient safety bill; 1.7 million Americans use health sharing arrangements; Next COVID vaccine should only target XBB strains
The top news stories in primary care today.
© Alena Kryazheva - stock.adobe.com
Texas governor signs patient safety bill
Gov. Greg Abbott signed a bill that will protect patients from dangerous doctors. HB 1998 will make it a Class A misdemeanor to lie on medical license applications, prevent doctors from practicing in Texas if they’ve been convicted, and require all physicians to be monitored monthly among other things. The change comes five years after the infamous Texas surgeon, “Dr. Death” was sentenced to life in prison.
1.7 million Americans use health sharing arrangements
The first national count of Americans who rely on health sharing plans reports that the number is extremely high – 1.7 million. Sharing plans do not guarantee payment for health services. Many of the plans ask members for charitable donations as well.
Next COVID vaccine should only target XBB strains
The Food and Drug Administration is recommending that the next COVID vaccine only target XBB strains. The XBB strains are proving to be more difficult than prior Omicron subvariants. Currently, in the United States XBB strains account for 98% of cases. Worldwide, XBB strains account for 95% of cases.
